Olmesartan vs. ramipril in elderly hypertensive patients: review of data from two published randomized, double-blind studies.
about
Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines.Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Terms of Major Cardiovascular Disease Outcomes in Elderly Patients: A Nationwide Population-Based Cohort StudyEffect of antihypertensive treatment on 24-h blood pressure variability: pooled individual data analysis of ambulatory blood pressure monitoring studies based on olmesartan mono or combination treatment.Pharmacovigilance database search discloses ClC-K channels as a novel target of the AT1 receptor blockers valsartan and olmesartan.
P2860
Olmesartan vs. ramipril in elderly hypertensive patients: review of data from two published randomized, double-blind studies.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Olmesartan vs. ramipril in eld ...... domized, double-blind studies.
@ast
Olmesartan vs. ramipril in eld ...... domized, double-blind studies.
@en
type
label
Olmesartan vs. ramipril in eld ...... domized, double-blind studies.
@ast
Olmesartan vs. ramipril in eld ...... domized, double-blind studies.
@en
prefLabel
Olmesartan vs. ramipril in eld ...... domized, double-blind studies.
@ast
Olmesartan vs. ramipril in eld ...... domized, double-blind studies.
@en
P2093
P2860
P1476
Olmesartan vs. ramipril in eld ...... ndomized, double-blind studies
@en
P2093
Ettore Malacco
Jean-Michel Mallion
Paolo Fabrizzi
P2860
P2888
P356
10.1007/S40292-013-0037-9
P577
2014-01-17T00:00:00Z